GLP-1 Medical Weight Loss in Provo, UT
What GLP-1 Medications Are Used for Medical Weight Loss?
Personalized Medical Weight Loss Plans
Weight loss in Provo at Avara Medical is approached as a medical and metabolic process—not a one-size-fits-all program. We focus on identifying the biological factors that influence weight, appetite, and metabolism, then tailoring treatment accordingly. Weight loss therapy at Avara Medical may include GLP-1–based and multi-agonist peptide medications such as semaglutide, tirzepatide, and retatrutide.
Semaglutide
Semaglutide is a GLP-1–based peptide that mimics a naturally occurring hormone involved in hunger and satiety. It works by helping patients feel full sooner and reducing overall caloric intake. Used for:
Appetite regulation
Reduced food cravings
Supporting sustainable weight loss
Tirzepatide
Tirzepatide is a dual-agonist peptide that acts on multiple hormonal pathways involved in appetite and metabolism. This multi-pathway approach may be beneficial for patients with more complex metabolic needs. Used for:
Appetite and blood sugar regulation
Metabolic support
Weight-related health concerns
Retatrutide
Retatrutide is an emerging multi-agonist peptide that influences appetite and energy regulation through several pathways. It may be considered as part of a personalized treatment plan based on clinical evaluation. Used for:
Appetite suppression
Fat metabolism support
Advanced metabolic signaling
Weight Loss Frequently Asked Questions
We offer semaglutide, tirzepatide, and retatrutide as part of medically supervised weight loss programs. The specific medication is selected based on your health history, goals, and medical evaluation.
Semaglutide is a GLP-1 medication that mimics a naturally occurring hormone involved in hunger and satiety. It helps you feel full sooner and reduces overall caloric intake, supporting sustainable weight loss when combined with lifestyle modifications. GLP-1s also help with food addictions and cravings making it a well-rounded treatment option for weight loss.
Tirzepatide is a dual-agonist that acts on multiple hormonal pathways, GLP-1 and GIP, affecting appetite and metabolism, while semaglutide is a single GLP-1 agonist. Tirzepatide tends to be more effective and have fewer side effects.
Weight loss results vary significantly by individual. Clinical studies show average weight loss of 10-20% of body weight over 6-12 months, but your results will depend on many factors including starting weight, adherence, and lifestyle habits.
Our programs include ongoing follow-up appointments, monitoring for side effects, dose adjustments as needed, nutritional guidance, body composition measurements and support for sustainable lifestyle changes. We emphasize safety and long-term success.
Common side effects include nausea, vomiting, heartburn, changes in bowel habits, and reduced appetite. Most side effects are mild and improve over time. We provide strategies to manage side effects and adjust dosing if needed.
This varies by individual. Some patients maintain weight loss after stopping medication if they've made sustainable lifestyle changes, while others may regain weight. We help you develop strategies for long-term weight maintenance off the medication.
Candidacy depends on multiple factors including BMI, health conditions, weight loss goals, and medical evaluation. We assess each patient individually to determine if GLP-1 therapy is appropriate and safe.
GLP-1 medications are FDA-approved for specific uses and must be prescribed and monitored by a qualified medical provider. Avara Medical emphasizes safety, monitoring, and ongoing follow-up for all weight loss programs.
Avara Medical may offer semaglutide as part of a medically supervised weight loss program when appropriate. Eligibility is determined through a medical evaluation, including health history and individual goals.